2022 Glaucoma Australia ‘Quinlivan’ research grants open
Researchers in glaucoma have until 31 May 2022 to apply for Glaucoma Australia’s annual ‘Quinlivan’ Research Grants, with the successful ...
Researchers in glaucoma have until 31 May 2022 to apply for Glaucoma Australia’s annual ‘Quinlivan’ Research Grants, with the successful ...
Glaucoma affects an estimated 300,000 Australians but half of them don't know it. Early detection is considered vital to prevent ...
Glaucoma Australia (GA) has launched a new initiative encouraging Australians to share a photo of “an amazing sight” every day ...
A UNSW researcher from the university’s Graduate School of Biomedical Engineering has been awarded Glaucoma Australia (GA)’s ‘Quinlivan’ Research Grant ...
Glaucoma Australia (GA) has opened the applications period for its annual ‘Quinlivan’ Research Grants program, with a funding pool of ...
Glaucoma Australia (GA) has appointed Ms Maree O’Brien as its new president who will replace the outgoing Associate Professor Simon ...
Glaucoma Australia (GA) has launched a new family-focused awareness campaign called 'Begins With You', to mobilise people diagnosed with glaucoma ...
An optometrist-turned-research fellow leading a world-first clinical trial investigating whether daily doses of vitamin B3 could prevent glaucoma blindness has ...
Preliminary results of a study targeting the most at-risk relatives of glaucoma patients suggest approximately 38% have the disease or ...
Glaucoma Australia (GA) has announced it is awarding $200,000 in new funding for 2021 research projects that support its aim ...
Insight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.
© 2024 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited
© 2024 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited